The European Conference on Rare Diseases and Orphan Products is the one event where everyone from patients, to policy makers, healthcare professionals, industry, payers, regulators, researchers and academics are given the opportunity to meet, exchange information and ideas and join together in the fight against rare
diseases. This event provides a unique platform comprising all rare diseases, across all European nations.
diseases. This event provides a unique platform comprising all rare diseases, across all European nations.
Lidia Canovas, our General Manager Regulatory Affairs, and our US Agent, Bruce Thompson, Principal and Consultant of Reguliance, attended as exhibitors at the Reguliance table.
Reguliance is Asphalion’s US Agent for US orphan drug applications, IND applications, drug and biologic master files (DMFs), and facilities registrations.
